Covaxin, Bharat Biotech’s Covid 19 vaccine works with the new Delta variant of the virus, finds a new study published by the Indian Council of Medical Research. In medical lingo, the Delta variant is referred to as B.1.617.2. Not only is it highly contagious, but also responsible for the second wave in India.

Covaxin is a whole virion inactivated SARS-CoV-2 vaccine which is being prescribed for large-scale immunisation in India. It has been found to be 65.2 percent effective against the Delta variant. Delta had further mutated into three sub-variants, of which Delta had mutated to the first sub-variant in 2021 in India, and 20 other countries, the study has concluded. Against symptomatic Covid the vaccine was found to be 77.8 percent effective.